Delivery Order SPE2DB22D3301-SPE2DB24FY9MS

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $9,385.28 and covers the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA). The contract, valued at $1,607.25, is a Delivery Order with a Firm Fixed Price pricing type. The award covers the delivery of Trileptal, a 300 mg/5 ml suspension medication, with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Trileptal 300 mg/5 ml suspension. The $2,368.56 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a $1,890.63 order for the pharmaceutical product Trileptal 300 mg/5 ml suspension. The contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award, valued at $16,958.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567829232 TRILEPTAL 300 MG TABLET 100S, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Trileptal 300 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $10,177.84 and an ultimate completion date of September 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution company serving the U.S. federal government, particularly the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,264.89 firm fixed-price delivery order contract is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, to support federal healthcare programs. The award has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.43, is for the delivery of Trileptal 300 mg/5 ml suspension, a pharmaceutical product, with a completion date of January 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award, valued at $5,180.00, is a firm-fixed price contract without any set-aside designation. The period of performance for this delivery order extends through August 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9MS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $3,283.70 for the supply of Trileptal 300 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/27/24, 9:13 AM